{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:03:56Z","timestamp":1777485836662,"version":"3.51.4"},"reference-count":115,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wellcome\/HRB Irish Clinical Academic Training (ICAT) Programme","award":["203930\/B\/16\/Z"],"award-info":[{"award-number":["203930\/B\/16\/Z"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Malignant melanoma, one of the most aggressive human malignancies, is responsible for 80% of skin cancer deaths. Whilst early detection of disease progression or metastasis can improve patient survival, this remains a challenge due to the lack of reliable biomarkers. Importantly, these clinical challenges are not unique to humans, as melanoma affects many other species, including companion animals, such as the dog and horse. Extracellular vesicles (EVs) are tiny nanoparticles involved in cell-to-cell communication. Several protein and genomic EV markers have been described in the literature, as well as a wide variety of methods for isolating EVs from body fluids. As such, they may be valuable biomarkers in cancer and may address some clinical challenges in the management melanoma. This review aimed to explore the translational applications of EVs as biomarkers in melanoma, as well as their role in the clinical setting in humans and animals. A summary of melanoma-specific protein and genomic EV markers is presented, followed by a discussion of the role EVs in monitoring disease progression and treatment response. Finally, herein, we reviewed the advantages and disadvantages of methods utilised to isolate EVs from bodily fluids in melanoma patients (human and animals) and describe some of the challenges that will need to be addressed before EVs can be introduced in the clinical setting.<\/jats:p>","DOI":"10.3390\/ph13120475","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T11:42:09Z","timestamp":1608291729000},"page":"475","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Circulating Melanoma-Derived Extracellular Vesicles: Impact on Melanoma Diagnosis, Progression Monitoring, and Treatment Response"],"prefix":"10.3390","volume":"13","author":[{"given":"Stephanie M.","family":"Bollard","sequence":"first","affiliation":[{"name":"UCD School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Belfield, Dublin 4, Ireland"},{"name":"The Charles Institute for Dermatology, School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Belfield, Dublin 4, Ireland"},{"name":"UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland"},{"name":"Department of Plastic &amp; Reconstructive Surgery, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland"},{"name":"Mater Melanoma Group, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-2783","authenticated-orcid":false,"given":"Cristina","family":"Casalou","sequence":"additional","affiliation":[{"name":"The Charles Institute for Dermatology, School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Belfield, Dublin 4, Ireland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-9986","authenticated-orcid":false,"given":"Chia Yin","family":"Goh","sequence":"additional","affiliation":[{"name":"UCD School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Belfield, Dublin 4, Ireland"},{"name":"UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland"}]},{"given":"Desmond J.","family":"Tobin","sequence":"additional","affiliation":[{"name":"The Charles Institute for Dermatology, School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Belfield, Dublin 4, Ireland"},{"name":"UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3047-8465","authenticated-orcid":false,"given":"Pamela","family":"Kelly","sequence":"additional","affiliation":[{"name":"UCD School of Veterinary Medicine, College of Health and Agricultural Sciences, University College Dublin, Belfield, Dublin 4, Ireland"}]},{"given":"Amanda","family":"McCann","sequence":"additional","affiliation":[{"name":"UCD School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Belfield, Dublin 4, Ireland"},{"name":"UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland"}]},{"given":"Shirley M.","family":"Potter","sequence":"additional","affiliation":[{"name":"UCD School of Medicine, College of Health and Agricultural Sciences, University College Dublin, Belfield, Dublin 4, Ireland"},{"name":"Department of Plastic &amp; Reconstructive Surgery, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland"},{"name":"Mater Melanoma Group, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2017.12.024","article-title":"Trends in incidence of thick, thin and in situ melanoma in Europe","volume":"92","author":"Sacchetto","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","article-title":"Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992\u20132013","volume":"76","author":"Landow","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/jid.2014.452","article-title":"More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, Australia","volume":"135","author":"Whiteman","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/CMR.0b013e32833716f9","article-title":"Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?","volume":"20","author":"Leiter","year":"2010","journal-title":"Melanoma Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.5505","article-title":"Spontaneously occurring melanoma in animals and their relevance to human melanoma","volume":"252","author":"Brenn","year":"2020","journal-title":"J. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Prouteau, A., and Andre, C. (2019). Canine Melanomas as Models for Human Melanomas: Clinical, Histological, and Genetic Comparison. Genes, 10.","DOI":"10.3390\/genes10070501"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nishiya, A.T., Massoco, C.O., Felizzola, C.R., Perlmann, E., Batschinski, K., Tedardi, M.V., Garcia, J.S., Mendonca, P.P., Teixeira, T.F., and Zaidan Dagli, M.L. (2016). Comparative Aspects of Canine Melanoma. Vet. Sci., 3.","DOI":"10.3390\/vetsci3010007"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41467-018-08081-1","article-title":"Cross-species genomic landscape comparison of human mucosal melanoma with canine oral and equine melanoma","volume":"10","author":"Wong","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/pcmr.12185","article-title":"Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma","volume":"27","author":"Simpson","year":"2014","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.blre.2012.12.002","article-title":"Extracellular vesicles in physiological and pathological conditions","volume":"27","author":"Yuana","year":"2013","journal-title":"Blood Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Thery","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrd3978","article-title":"Extracellular vesicles: Biology and emerging therapeutic opportunities","volume":"12","author":"Breakefield","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Aguilera-Rojas, M., Badewien-Rentzsch, B., Plendl, J., Kohn, B., and Einspanier, R. (2018). Exploration of serum- and cell culture-derived exosomes from dogs. BMC Vet. Res., 14.","DOI":"10.1186\/s12917-018-1509-x"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Klymiuk, M.C., Balz, N., Elashry, M.I., Heimann, M., Wenisch, S., and Arnhold, S. (2019). Exosomes isolation and identification from equine mesenchymal stem cells. BMC Vet. Res., 15.","DOI":"10.1186\/s12917-019-1789-9"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Fish, E.J., Irizarry, K.J., DeInnocentes, P., Ellis, C.J., Prasad, N., Moss, A.G., and Bird, R.C. (2018). Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4750-6"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"9484","DOI":"10.1038\/s41598-019-45857-x","article-title":"Oviductal extracellular vesicles interact with the spermatozoon\u2019s head and mid-piece and improves its motility and fertilizing ability in the domestic cat","volume":"9","author":"Ferraz","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15375","DOI":"10.18632\/oncotarget.3801","article-title":"Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes","volume":"6","author":"Keerthikumar","year":"2015","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1722433","DOI":"10.1080\/20013078.2020.1722433","article-title":"Subpopulations of extracellular vesicles from human metastatic melanoma tissue identified by quantitative proteomics after optimized isolation","volume":"9","author":"Crescitelli","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"22519","DOI":"10.1038\/srep22519","article-title":"Cells release subpopulations of exosomes with distinct molecular and biological properties","volume":"6","author":"Willms","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2019.12.046","article-title":"Exosomes in triple negative breast cancer: Garbage disposals or Trojan horses?","volume":"473","author":"Goh","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"20826","DOI":"10.18632\/oncotarget.24846","article-title":"Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity","volume":"9","author":"Tucci","year":"2018","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/ncb3404","article-title":"Melanosomes foster a tumour niche by activating CAFs","volume":"18","author":"Peinado","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nm.2753","article-title":"Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET","volume":"18","author":"Peinado","year":"2012","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1158\/0008-5472.CAN-10-4455","article-title":"Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis","volume":"71","author":"Hood","year":"2011","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/pcmr.12380","article-title":"Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines","volume":"28","author":"Lazar","year":"2015","journal-title":"Pigm. Cell Melanoma Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Biomarkers Definitions Working Group (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin. Pharmacol. Ther., 69, 89\u201395.","DOI":"10.1067\/mcp.2001.113989"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature06913","article-title":"The cancer biomarker problem","volume":"452","author":"Sawyers","year":"2008","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1039\/C4CS00370E","article-title":"Cancer biomarker detection: Recent achievements and challenges","volume":"44","author":"Wu","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI81135","article-title":"The biology and function of exosomes in cancer","volume":"126","author":"Kalluri","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"86999","DOI":"10.18632\/oncotarget.13569","article-title":"Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers","volume":"7","author":"Hurwitz","year":"2016","journal-title":"Oncotarget"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41392-020-00258-9","article-title":"Application of exosomes as liquid biopsy in clinical diagnosis","volume":"5","author":"Zhou","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biopen.2017.02.004","article-title":"Purified horse milk exosomes contain an unpredictable small number of major proteins","volume":"4","author":"Sedykh","year":"2017","journal-title":"Biochim. Open"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20181522","article-title":"Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation","volume":"216","author":"Mazariegos","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.3389\/fonc.2020.580891","article-title":"Proteomic Profiling of Plasma and Total Blood Exosomes in Breast Cancer: A Potential Role in Tumor Progression, Diagnosis, and Prognosis","volume":"10","author":"Tutanov","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cca.2019.05.028","article-title":"What information can be obtained from the tears of a patient with primary open angle glaucoma?","volume":"495","author":"Tamkovich","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"15745","DOI":"10.1038\/s41598-020-72834-6","article-title":"Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients","volume":"10","author":"Zocco","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.semcancer.2019.06.020","article-title":"Natural melanoma-derived extracellular vesicles","volume":"59","author":"Hood","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zmigrodzka, M., Witkowska-Pilaszewicz, O., Rzepecka, A., Cywinska, A., Jagielski, D., and Winnicka, A. (2019). Extracellular Vesicles in the Blood of Dogs with Cancer-A Preliminary Study. Animals, 9.","DOI":"10.3390\/ani9080575"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/pmic.201300282","article-title":"Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma","volume":"13","author":"Kalra","year":"2013","journal-title":"Proteomics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41598-020-57497-7","article-title":"A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum","volume":"10","author":"Brennan","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1153124","article-title":"Ceramide triggers budding of exosome vesicles into multivesicular endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1038\/jid.2010.141","article-title":"Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma","volume":"130","author":"Pinzani","year":"2010","journal-title":"J. Investig. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1159\/000458736","article-title":"Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Maisano, D., Mimmi, S., Russo, R., Fioravanti, A., Fiume, G., Vecchio, E., Nistico, N., Quinto, I., and Iaccino, E. (2020). Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring. Pharmaceuticals, 13.","DOI":"10.3390\/ph13080180"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Moloney, B.M., Gilligan, K.E., Joyce, D.P., O\u2019Neill, C.P., O\u2019Brien, K.P., Khan, S., Glynn, C.L., Waldron, R.M., Maguire, C.M., and Holian, E. (2020). Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast Cancer. Cells, 9.","DOI":"10.3390\/cells9010141"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-017-0706-8","article-title":"Role of exosomal proteins in cancer diagnosis","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","article-title":"Malignant effusions and immunogenic tumour-derived exosomes","volume":"360","author":"Andre","year":"2002","journal-title":"Lancet"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41598-019-56542-4","article-title":"Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells","volume":"10","author":"Sharma","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1710899","DOI":"10.1080\/20013078.2019.1710899","article-title":"Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients","volume":"9","author":"Cordonnier","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1002\/pmic.200400876","article-title":"Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry","volume":"4","author":"Mears","year":"2004","journal-title":"Proteomics"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Logozzi, M., De Milito, A., Lugini, L., Borghi, M., Calabr\u00f2, L., Spada, M., Perdicchio, M., Marino, M.L., Federici, C., and Iessi, E. (2009). High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005219"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1002\/ijc.32521","article-title":"Melanoma-derived extracellular vesicles instigate proinflammatory signaling in the metastatic microenvironment","volume":"145","author":"Adler","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1435138","DOI":"10.1080\/20013078.2018.1435138","article-title":"Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma","volume":"7","author":"Sharma","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3390\/jcm4121957","article-title":"Detection of Exosomal miRNAs in the Plasma of Melanoma Patients","volume":"4","author":"Pfeffer","year":"2015","journal-title":"J. Clin. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Xiao, D., Ohlendorf, J., Chen, Y., Taylor, D.D., Rai, S.N., Waigel, S., Zacharias, W., Hao, H., and McMasters, K.M. (2012). Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046874"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/CMR.0000000000000450","article-title":"Serum exosomal microRNAs as potent circulating biomarkers for melanoma","volume":"28","author":"Tengda","year":"2018","journal-title":"Melanoma Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Gerloff, D., Lutzkendorf, J., Moritz, R.K.C., Wersig, T., Mader, K., Muller, L.P., and Sunderkotter, C. (2020). Melanoma-Derived Exosomal miR-125b-5p Educates Tumor Associated Macrophages (TAMs) by Targeting Lysosomal Acid Lipase A (LIPA). Cancers, 12.","DOI":"10.3390\/cancers12020464"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"828","DOI":"10.5858\/arpa.2013-0134-OA","article-title":"Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma","volume":"138","author":"Alegre","year":"2014","journal-title":"Arch. Pathol Lab. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jcmm.12030","article-title":"Caveolin-1 as a promoter of tumour spreading: When, how, where and why","volume":"17","author":"Senetta","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.yexcr.2017.07.011","article-title":"Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells","volume":"358","author":"Troyer","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/85438","article-title":"Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming","volume":"7","author":"Wolfers","year":"2001","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/carcin\/bgt111","article-title":"The HSP70 family and cancer","volume":"34","author":"Murphy","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"djv330","DOI":"10.1093\/jnci\/djv330","article-title":"Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer","volume":"108","author":"Gobbo","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s12192-019-01024-9","article-title":"7Hsp70 serum levels in pet dogs-a potential diagnostic biomarker for spontaneous round cell tumors","volume":"24","author":"Salvermoser","year":"2019","journal-title":"Cell Stress Chaperones"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40814-020-00577-2","article-title":"Membrane-bound exosomal HSP70 as a biomarker for detection and monitoring of malignant solid tumours: A pilot study","volume":"6","author":"Chanteloup","year":"2020","journal-title":"Pilot Feasibility Stud."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"London, C., Bear, M., McCleese, J., Foley, K., Paalangara, R., Inoue, T., Ying, W., and Barsoum, J. (2011). Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027018"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.vaccine.2011.02.031","article-title":"Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model","volume":"29","author":"Yu","year":"2011","journal-title":"Vaccine"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/ijc.24451","article-title":"Caveolin-1 tumor-promoting role in human melanoma","volume":"125","author":"Felicetti","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Surman, M., St\u0229pie\u0144, E., and Przyby\u0142o, M. (2019). Melanoma-derived extracellular vesicles: Focus on their proteome. Proteomes, 7.","DOI":"10.3390\/proteomes7020021"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-4615-0685-0_49","article-title":"Exosomes in cancer immunotherapy: Preclinical data","volume":"495","author":"Andre","year":"2001","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/pcmr.12067","article-title":"PMEL: A pigment cell-specific model for functional amyloid formation","volume":"26","author":"Watt","year":"2013","journal-title":"Pigment. Cell Melanoma Res."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Guerreiro, E.M., Ovstebo, R., Thiede, B., Costea, D.E., Soland, T.M., and Kanli Galtung, H. (2020). Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0238591"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/1078-0432.CCR-13-3042","article-title":"CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA","volume":"20","author":"Riccardo","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.tvjl.2011.02.020","article-title":"Chondroitin sulfate proteoglycan-4: A biomarker and a potential immunotherapeutic target for canine malignant melanoma","volume":"190","author":"Mayayo","year":"2011","journal-title":"Vet. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cca.2015.12.031","article-title":"Circulating melanoma exosomes as diagnostic and prognosis biomarkers","volume":"454","author":"Alegre","year":"2016","journal-title":"Clin. Chim Acta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Bardi, G.T., Al-Rayan, N., Richie, J.L., Yaddanapudi, K., and Hood, J.L. (2019). Detection of inflammation-related melanoma small extracellular vesicle (sEV) mRNA content using primary melanocyte sEVs as a reference. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051235"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00428-007-0532-2","article-title":"MicroRNA: Implications for cancer","volume":"452","author":"Sassen","year":"2008","journal-title":"Virchows Arch."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Loria, A.D., Dattilo, V., Santoro, D., Guccione, J., De Luca, A., Ciaramella, P., Pirozzi, M., and Iaccino, E. (2020). Expression of Serum Exosomal miRNA 122 and Lipoprotein Levels in Dogs Naturally Infected by Leishmania infantum: A Preliminary Study. Animals, 10.","DOI":"10.3390\/ani10010100"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/jvim.15764","article-title":"Circulating microRNA as biomarkers of canine mammary carcinoma in dogs","volume":"34","author":"Fish","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ingenito, F., Roscigno, G., Affinito, A., Nuzzo, S., Scognamiglio, I., Quintavalle, C., and Condorelli, G. (2019). The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194687"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.canlet.2016.03.050","article-title":"Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine\/autocrine signaling in the tumor microenvironment","volume":"376","author":"Xiao","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"15763","DOI":"10.1002\/jcp.28234","article-title":"Blockage of transferred exosome-shuttled miR-494 inhibits melanoma growth and metastasis","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1111\/cas.13310","article-title":"Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells","volume":"108","author":"Matsumoto","year":"2017","journal-title":"Cancer Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-0811-2","article-title":"Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma","volume":"14","author":"Felicetti","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Maekawa, N., Konnai, S., Okagawa, T., Nishimori, A., Ikebuchi, R., Izumi, Y., Takagi, S., Kagawa, Y., Nakajima, C., and Suzuki, Y. (2016). Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157176"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1038\/s41598-017-09444-2","article-title":"A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma","volume":"7","author":"Maekawa","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Ganbaatar, O., Konnai, S., Okagawa, T., Nojima, Y., Maekawa, N., Minato, E., Kobayashi, A., Ando, R., Sasaki, N., and Miyakosi, D. (2020). PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade. bioRxiv.","DOI":"10.1101\/2020.05.22.110395"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/acs.molpharmaceut.7b00950","article-title":"Role of Extracellular Vesicle Surface Proteins in the Pharmacokinetics of Extracellular Vesicles","volume":"15","author":"Charoenviriyakul","year":"2018","journal-title":"Mol. Pharm."},{"key":"ref_94","unstructured":"DePeralta, D., Michaud, W., Hammond, M., and Boland, G. (2016, January 2\u20134). 44.03 Circulating Microvesicles, Exosomes, are Enriched in Melanoma and correlate with Tumor Burden. Proceedings of the Academic Surgical Congress, Jacksonville, FL, USA."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50848-z","article-title":"Extracellular Vesicles Shedding Promotes Melanoma Growth in Response to Chemotherapy","volume":"9","author":"Andrade","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"E5930","DOI":"10.1073\/pnas.1705206114","article-title":"BRAF V600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells","volume":"114","author":"Lunavat","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cveq.2019.04.003","article-title":"Treatment options for melanoma of gray Horses","volume":"35","author":"MacKay","year":"2019","journal-title":"Vet. Clin. Equine Pract."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Bergman, P.J. (2020). Melanoma. Clinical Small Animal Internal Medicine, Wiley.","DOI":"10.1002\/9781119501237.ch153"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"20371","DOI":"10.1038\/s41598-020-77366-7","article-title":"Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas","volume":"10","author":"Garnica","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cyto.2018.02.002","article-title":"Melanoma exosomes promote mixed M1 and M2 macrophage polarization","volume":"105","author":"Bardi","year":"2018","journal-title":"Cytokine"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.2016.4059","article-title":"Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma","volume":"315","author":"Ribas","year":"2016","journal-title":"JAMA"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/bjc.2018.9","article-title":"PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC","volume":"118","author":"Marconcini","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e1387706","DOI":"10.1080\/2162402X.2017.1387706","article-title":"Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma","volume":"7","author":"Tucci","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Federici, C., Petrucci, F., Caimi, S., Cesolini, A., Logozzi, M., Borghi, M., D\u2019Ilio, S., Lugini, L., Violante, N., and Azzarito, T. (2014). Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088193"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-018-0886-x","article-title":"A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells","volume":"17","author":"Cesi","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Palviainen, M., Saraswat, M., Varga, Z., Kitka, D., Neuvonen, M., Puhka, M., Joenvaara, S., Renkonen, R., Nieuwland, R., and Takatalo, M. (2020). Extracellular vesicles from human plasma and serum are carriers of extravesicular cargo-Implications for biomarker discovery. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0236439"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.1038\/s41598-018-35401-8","article-title":"Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking Analysis","volume":"8","author":"Jamaly","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Royo, F., Thery, C., Falcon-Perez, J.M., Nieuwland, R., and Witwer, K.W. (2020). Methods for Separation and Characterization of Extracellular Vesicles: Results of a Worldwide Survey Performed by the ISEV Rigor and Standardization Subcommittee. Cells, 9.","DOI":"10.3390\/cells9091955"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1692401","DOI":"10.1080\/20013078.2019.1692401","article-title":"Purity and yield of melanoma exosomes are dependent on isolation method","volume":"9","author":"Shu","year":"2020","journal-title":"J. Extracell Vesicles"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3389\/fphys.2018.01479","article-title":"Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography From Blood Plasma","volume":"9","author":"Onodi","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.4185","article-title":"EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research","volume":"14","author":"Consortium","year":"2017","journal-title":"Nat. Methods"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.18632\/oncotarget.14443","article-title":"Investigating the utility of human melanoma cell lines as tumour models","volume":"8","author":"Vincent","year":"2017","journal-title":"Oncotarget"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fimmu.2016.00282","article-title":"Melanoma affects the composition of blood cell-derived extracellular vesicles","volume":"7","author":"Koliha","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0219-1","article-title":"Exploiting the message from cancer: The diagnostic value of extracellular vesicles for clinical applications","volume":"51","author":"Kosaka","year":"2019","journal-title":"Exp. Mol. Med."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/13\/12\/475\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:46:58Z","timestamp":1760179618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/13\/12\/475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,18]]},"references-count":115,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["ph13120475"],"URL":"https:\/\/doi.org\/10.3390\/ph13120475","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,18]]}}}